BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Kim SR, Shin K, Park JM, Lee HH, Song KY, Lee SH, Kim B, Kim SY, Seo J, Kim JO, Roh SY, Kim IH. Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer. J Gastric Cancer 2020;20:408-20. [PMID: 33425442 DOI: 10.5230/jgc.2020.20.e33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Abyadeh M, Meyfour A, Gupta V, Zabet Moghaddam M, Fitzhenry MJ, Shahbazian S, Hosseini Salekdeh G, Mirzaei M. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers. Int J Mol Sci 2020;21:E8532. [PMID: 33198323 DOI: 10.3390/ijms21228532] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sremac M, Paic F, Grubelic Ravic K, Serman L, Pavicic Dujmovic A, Brcic I, Krznaric Z, Nikuseva Martic T. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma. Oncol Lett 2021;22:822. [PMID: 34691249 DOI: 10.3892/ol.2021.13083] [Reference Citation Analysis]
4 Okayasu I, Ichinoe M, Yoshida T. Proposal for an Organ-Specific Chronic Inflammation–Remodeling–Carcinoma Sequence. GastrointestDisord 2019;1:341-57. [DOI: 10.3390/gidisord1030028] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Aronson M, Swallow C, Govindarajan A, Semotiuk K, Cohen Z, Kaurah P, Velsher L, Ambus I, Buckley K, Forster-Gibson C, Meschino WS, Blumenthal A, Kim RH, Brar S. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer. Curr Oncol 2020;27:e182-90. [PMID: 32489267 DOI: 10.3747/co.27.5663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liliac IM, Ungureanu BS, Mărgăritescu C, Sacerdoțianu VM, Săftoiu A, Mogoantă L, Moraru E, Pirici D. E-Cadherin Modulation and Inter-Cellular Trafficking in Tubular Gastric Adenocarcinoma: A High-Resolution Microscopy Pilot Study. Biomedicines 2022;10:349. [DOI: 10.3390/biomedicines10020349] [Reference Citation Analysis]
7 Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer. J Surg Res 2021;266:27-34. [PMID: 33975027 DOI: 10.1016/j.jss.2021.04.005] [Reference Citation Analysis]
8 Chi Q, Xu H, Song D, Wang Z, Wang Z, Ma G. α-E-Catenin (CTNNA1) Inhibits Cell Proliferation, Invasion and EMT of Bladder Cancer. Cancer Manag Res 2020;12:12747-58. [PMID: 33364826 DOI: 10.2147/CMAR.S259269] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, Shin CM, Park YS, Lee DH, Oh HJ, Lee HS, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol 2022; 28(9): 933-947 [DOI: 10.3748/wjg.v28.i9.933] [Reference Citation Analysis]
10 Mwangi C, Njoroge S, Tshibangu-Kabamba E, Moloo Z, Rajula A, Devani S, Matsumoto T, Nyerere K, Kariuki S, Revathi G, Yamaoka Y. Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma. Toxins (Basel) 2020;12:E556. [PMID: 32872465 DOI: 10.3390/toxins12090556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Miyamoto S, Nagano Y, Miyazaki M, Nagamura Y, Sasaki K, Kawamura T, Yanagihara K, Imai T, Ohki R, Yashiro M, Tanaka M, Sakai R, Yamaguchi H. Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma. Cancer Lett 2021:S0304-3835(21)00575-9. [PMID: 34775002 DOI: 10.1016/j.canlet.2021.11.008] [Reference Citation Analysis]
12 Pinto C, Cunha A, Rodrigues Â, Dias R, Brandão C, Dinis-ribeiro M. Diagnosis of MALT Lymphoma from Surveillance Endoscopy of a Patient with a <b><i>CDH1</i></b> Gene Germline Mutation. GE Port J Gastroenterol 2022;29:51-5. [DOI: 10.1159/000514652] [Reference Citation Analysis]
13 Nakonieczna S, Grabarska A, Kukula-Koch W. The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer-A Review on In Vitro, In Vivo, and Clinical Studies. Int J Mol Sci 2020;21:E8307. [PMID: 33167519 DOI: 10.3390/ijms21218307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 González MF, Díaz P, Sandoval-Bórquez A, Herrera D, Quest AFG. Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development. Int J Mol Sci 2021;22:4823. [PMID: 34062919 DOI: 10.3390/ijms22094823] [Reference Citation Analysis]
15 Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z, Bai C, Zhao L, Han Q, Zhao RC, Wang X. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics 2022;12:620-38. [PMID: 34976204 DOI: 10.7150/thno.60540] [Reference Citation Analysis]
16 Reizine N, Peterson B, Moya S, Wang Y, Tan YCYH, Eng OS, Bilimoria M, Lengyel E, Turaga K, Catenacci DVT. Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy. JCO Precis Oncol 2020;4:PO. [PMID: 33215053 DOI: 10.1200/PO.20.00239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Toh JWT, Wilson RB. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int J Mol Sci 2020;21:E6451. [PMID: 32899442 DOI: 10.3390/ijms21176451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
18 Moslim MA, Deng M, Handorf E, Greco SH, Farma JM. Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers. Am J Surg 2021:S0002-9610(21)00287-7. [PMID: 34045068 DOI: 10.1016/j.amjsurg.2021.05.007] [Reference Citation Analysis]
19 Burandt E, Lübbersmeyer F, Gorbokon N, Büscheck F, Luebke AM, Menz A, Kluth M, Hube-Magg C, Hinsch A, Höflmayer D, Weidemann S, Fraune C, Möller K, Jacobsen F, Lebok P, Clauditz TS, Sauter G, Simon R, Uhlig R, Wilczak W, Steurer S, Minner S, Krech R, Dum D, Krech T, Marx AH, Bernreuther C. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. Biomark Res 2021;9:44. [PMID: 34090526 DOI: 10.1186/s40364-021-00299-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 De Re V. Molecular Features Distinguish Gastric Cancer Subtypes. Int J Mol Sci 2018;19:E3121. [PMID: 30314372 DOI: 10.3390/ijms19103121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
21 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
22 Xie Y, Liu Z, Zhu H. Knockdown of hsa_circ_0091994 constrains gastric cancer progression by suppressing the miR-324-5p/HMGA1 axis. Aging (Albany NY) 2021;13:20598-608. [PMID: 34483139 DOI: 10.18632/aging.203450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ji J, Wang Z, Sun W, Li Z, Cai H, Zhao E, Cui H. Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer. Int J Mol Sci 2021;22:12125. [PMID: 34830011 DOI: 10.3390/ijms222212125] [Reference Citation Analysis]
24 Li G, Zhang T, Huang K, Zhu Y, Xu K, Gu J, Huang S, Gu C, Zhan R, Shen J. Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases. Biomed Pharmacother 2021;139:111572. [PMID: 33838502 DOI: 10.1016/j.biopha.2021.111572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yoon BK, Hwang N, Chun KH, Lee Y, Duarte TPM, Kim JW, Kim TH, Cheong JH, Fang S, Kim JW. Sp1-Induced FNBP1 Drives Rigorous 3D Cell Motility in EMT-Type Gastric Cancer Cells. Int J Mol Sci 2021;22:6784. [PMID: 34202606 DOI: 10.3390/ijms22136784] [Reference Citation Analysis]
26 Li J. Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis. Gastroenterol Res Pract 2020;2020:9512707. [PMID: 32190044 DOI: 10.1155/2020/9512707] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
27 Tang H, Liang Y, Xu S, Xia R, Shen J, Zhang Y, Gong X, Min Y, Zhang D, Zhao T, Wang S, Zhang Y, Wang C. Expression of Four Autophagy-Related Genes Accurately Predicts the Prognosis of Gastrointestinal Cancer in Asian Patients. Dis Markers 2021;2021:7253633. [PMID: 34484469 DOI: 10.1155/2021/7253633] [Reference Citation Analysis]
28 Zhang G, Li L, Bi J, Wu Y, Li E. Targeting DNA and mutant p53 by a naphthalimide derivative, NA20, exhibits selective inhibition in gastric tumorigenesis by blocking mutant p53-EGFR signaling pathway. Eur J Pharmacol 2020;887:173584. [PMID: 32950500 DOI: 10.1016/j.ejphar.2020.173584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Abdelhakeem AA, Wang X, Waters RE, Patnana M, Estrella JS, Blum Murphy M, Trail AM, Lu Y, Devine CE, Ikoma N, Das P, Badgwell BD, Rogers JE, Ajani JA. Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response. Cancers (Basel) 2021;13:420. [PMID: 33498613 DOI: 10.3390/cancers13030420] [Reference Citation Analysis]
30 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
31 Yelskaya Z, Arnold AG, Marcell VJ, Tang LH, Salo-Mullen EE, Strong VE, Stadler ZK, Zhang L. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant. Eur J Hum Genet 2021;29:1103-9. [PMID: 33619332 DOI: 10.1038/s41431-021-00825-w] [Reference Citation Analysis]